伴嗜酸性粒细胞增多和全身症状的药物反应(DRESS):三级医疗中心回顾性研究
最常见致病药物为抗菌药物(74%)和抗惊厥药(21%),95%患者出现嗜酸性粒细胞增多,病死率5%。
要点
- 致病药物以抗菌药物(74%)和抗惊厥药(21%)最常见,用药后皮疹中位出现时间3.7周。
- 嗜酸性粒细胞增多(≥0.7×10^9/L)见于95%患者,多在皮疹出现后约10天达峰。
- 16例接受全身糖皮质激素治疗,平均恢复时间2周,病死率5%。
核心结论
- DRESS是一种发病率与病死率均较高的严重药物不良反应,仍需更多研究以加深认识。
研究设计与样本
- 患者年龄4至76岁,其中儿童4例、成人15例;女性10例(52.3%)。
主要发现
- 最常见致病药物为抗菌药物(74%)和抗惊厥药(21%);最常见合并症为癫痫(26%)和高血压(26%)。
- 全部患者均有皮肤表现,其中58%出现面部水肿;肝功能检查、尿素/肌酐和肌钙蛋白升高分别见于74%、32%和42%的患者。
- 皮疹出现距用药暴露的中位时间为3.7周(四分位距2.4-4.2周);嗜酸性粒细胞增多(≥0.7×10^9/L)见于95%患者,约在皮肤表现后10天达峰。
- 白细胞增多见于84%患者,反应性淋巴细胞见于26%患者;16例接受全身糖皮质激素治疗。
- 平均恢复时间为2周(四分位距2-3.5周),病死率为5%。
临床怎么用
- 对用药后3-6周出现发热、皮疹、面部水肿及内脏受累者应警惕DRESS,并参照RegiSCAR标准进行诊断评估。
- 监测嗜酸性粒细胞、肝肾功能、肌钙蛋白等指标有助于识别内脏受累并及时启动糖皮质激素治疗。
局限性
- 为单中心回顾性研究,样本量仅19例,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare, drug-induced severe adverse reaction that usually occurs 3-6 weeks after initial exposure to certain drugs. It affects mainly adults and children to a lesser extent. Clinical features include fever, facial oedema, generalized skin rash, lymphadenopathy, haematological abnormalities and internal organ involvement. The objective was to investigate the clinical and laboratory features of patients with DRESS in our centre. METHODS: We retrospectively describe and analyse 19 cases of DRESS whose diagnosis was based on the RegiSCAR criteria (≥6 points) that occurred from January 2009 to December 2019. RESULTS: Patient age ranged from 4 to 76 years (4 children/15 adults); 10 were female (52.3%). The most common culprit drugs were antibiotics (74%) and anticonvulsants (21%). The most common comorbidities were epilepsy (26%) and hypertension (26%). All patients developed cutaneous manifestations and of those, 58% presented facial oedema. Liver function tests, urea/creatinine and troponin elevation were present in 74, 32 and 42%, respectively. The median time to develop the skin rash after the drug exposure was 3.7 weeks (interquartile range 2.4-4.2 wk). Eosinophilia (≥0.7 × 109 /L) was present in 95% of the patients and peaked around 10 days after the skin manifestations. Leucocytosis and reactive lymphocytes were reported in 84% and 26% of all patients respectively. Treatment with systemic steroids was reported in 16 patients. The mean recovery time was 2 weeks (interquartile range 2-3.5 wk) and mortality was 5%. CONCLUSION: DRESS is a serious condition with significant morbidity and mortality, which requires more research for a better understanding.
引用
- Del Pozzo-Magaña BR, Rieder MJ, Garcia-Bournissen F, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): A tertiary care centre retrospective study. Br J Clin Pharmacol. 2022. PMID: 35421262. doi:10.1111/bcp.15354
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。